'%3e%3cmask%20id='b'%20fill='%23fff'%3e%3cuse%20xlink:href='%23a'/%3e%3c/mask%3e%3cpath%20fill='%2300567A'%20d='M11.208%2019.504c-1.1%200-1.886-.34-2.416-1.004-.397-.498-.583-1.165-.583-2.261V9.486h5.068a.389.389%200%200%200%20.387-.391v-3.47a.389.389%200%200%200-.387-.391H8.21V.574a.407.407%200%200%200-.405-.41H3.697a.407.407%200%200%200-.405.41v4.66H.405a.408.408%200%200%200-.405.41v3.433c0%20.226.182.41.405.41h2.887v6.307c0%202.577.402%204.214%201.345%205.473%201.284%201.732%203.454%202.647%206.274%202.647%202.173%200%203.562-.52%204.311-1.114.216-.172.26-.558.133-.741a426.14%20426.14%200%200%201-1.78-2.831c-.151-.248-.473-.305-.743-.156-.366.202-1.065.432-1.624.432'%20mask='url(%23b)'/%3e%3c/g%3e%3cpath%20fill='%2300567A'%20d='M23.332%208.968c1.54%200%203.31%201.184%203.514%203.1h-7.324c.232-1.5%201.739-3.1%203.81-3.1m0-4.034c-2.526%200-4.806%201.017-6.42%202.864-1.54%201.762-2.388%204.135-2.388%206.682%200%205.6%203.896%209.51%209.476%209.51%202.453%200%204.868-.902%206.571-2.407.076-.068.166-.154.258-.248a.412.412%200%200%200%20.038-.536l-1.946-2.593a.401.401%200%200%200-.6-.05c-.112.108-.246.23-.386.346-.805.658-2.109%201.453-3.824%201.453-2.564%200-4.536-1.735-4.814-4.227h11.964a.58.58%200%200%200%20.576-.524%209.2%209.2%200%200%200%20.043-.911c0-2.507-.852-4.847-2.398-6.589a8.122%208.122%200%200%200-6.15-2.77'/%3e%3cpath%20fill='%2300A03B'%20d='M40.817%2019.3l.008-2.616c.002-1.067.223-2.258.633-3.473.465-1.383%201.134-2.559%201.874-3.414l1.13-1.464v6.118l-3.645%204.85z'/%3e%3cpath%20fill='%23AFCB37'%20d='M44.462%208.333l2.4-3.11a.68.68%200%200%201%20.798-.23.769.769%200%200%201%20.475.731l-.018%203.864-3.655%204.863V8.333z'/%3e%3cpath%20fill='%233C7E79'%20d='M48.117%209.588l-.01%202.22c.037%201.14-.152%202.452-.6%203.781-.41%201.216-.944%202.283-1.578%203.102L44.462%2020.6v-6.148l3.655-4.863z'/%3e%3cpath%20fill='%2300567A'%20d='M44.463%2014.45v6.15l-2.383%203.1a.682.682%200%200%201-.8.231.77.77%200%200%201-.474-.732l.012-3.899%203.645-4.85z'/%3e%3cpath%20fill='%2300A03B'%20d='M40.3%2019.3l-.007-2.616c-.002-1.067-.223-2.258-.632-3.473-.466-1.383-1.134-2.559-1.875-3.414l-1.13-1.464v6.118L40.3%2019.3z'/%3e%3cpath%20fill='%23AFCB37'%20d='M36.656%208.333l-2.4-3.11a.68.68%200%200%200-.799-.23.77.77%200%200%200-.474.731L33%209.588l3.655%204.863V8.333z'/%3e%3cpath%20fill='%233C7E79'%20d='M33.001%209.588l.01%202.22c-.037%201.14.152%202.451.6%203.782.41%201.215.945%202.283%201.578%203.101l1.467%201.908v-6.148L33%209.588z'/%3e%3cpath%20fill='%2300567A'%20d='M36.656%2014.45v6.15l2.383%203.1a.682.682%200%200%200%20.8.231.77.77%200%200%200%20.474-.732L40.3%2019.3l-3.645-4.85z'/%3e%3c/g%3e%3c/svg%3e)
| Committees | Independence | |||
|---|---|---|---|---|
| Tal ZaksDirector | Finance and Investment, Science and Technology | Independent | 4 yr | Not disclosed |
1 seat
The board of the latest proxy statement.
Teva Pharmaceutical Industries: Board
| Committees | Independence | |||
|---|---|---|---|---|
| Tal ZaksDirector | Finance and Investment, Science and Technology | Independent | 4 yr | Not disclosed |
The board of the latest proxy statement.